Veeva Systems Inc. (VEEV) and BioMarin Pharmaceutical Inc. (BMRN) on Thursday announced a long-term enterprise agreement that extends their existing relationship.
Under the expanded partnership, BioMarin aims to boost speed, agility, and operational efficiency, while enhancing the experience for healthcare professionals and patients by leveraging and providng strategic input on Veeva's software, data, services, and consulting offerings.
"This strategic partnership marks an important next step in our digital evolution," said Alexander Hardy, President and Chief Executive Officer of BioMarin.
"Building on this foundation, I look forward to how we can further support BioMarin as they advance important new medicines and reach even more patients around the world," said Veeva CEO Peter Gassner.
On Wednesday, Veeva Systems shares rose 0.62% to $239.35, while BioMarin shares gained 2.06% to $61.31.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.